Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA Has Model Drug Facts Labels For OTC Naloxone, Needs Switch Proposals
Jan 21 2019
•
By
Malcolm Spicer
Model Drug Facts label project may help FDA address opioid crisis • Source: Shutterstock
More from Marketing & Advertising
More from Compliance